January 10, 2018
4,449
187
39
5.08%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
6:28Now PlayingIn this Majority Report clip, we talk about how Donald Trump's HHS nominee, Alex Azar, participated in extremely disgusting consumer practices while he was a top executive at Eli Lilly.
We need your help to keep providing free videos! Support the Majority Report's video content by going to
Watch the Majority Report live MF at 12 p.m. EST at youtube.com/samseder or listen via daily podcast at
Download our FREE app
SUPPORT the show by becoming a member
LIKE us on Facebook
FOLLOW us on Twitter
SUBSCRIBE to us on YouTube
---When Donald Trump’s nominee for HHS secretary was a top executive at Eli Lilly, the patent on its blockbuster Cialis was soon to expire.
So Lilly tested it on kids.
The drugmaker believed the erectile dysfunction drug might help a rare and deadly muscle-wasting disease that afflicts boys. The drug didn’t work — but under a law that promotes pediatric research, Lilly was able to extend the Cialis patent anyway for six months — and that’s worth a lot when a medication brings in over $2 billion a year.
Critics say the brand-name drugmakers are “gaming” the patent system, finding all sorts of ways to protect monopolies and delay competition from generics. And Alex Azar — the former president of Eli Lilly's U.S. operations, now poised to become the top U.S. health official — professes to oppose such tactics.---
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.